ASX:OPT - Opthea Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started A$0.65 -0.01 (-1.52 %) (As of 05/21/2019 04:00 PM ET)Previous CloseA$0.66Today's RangeA$0.65 - A$0.6652-Week RangeA$0.42 - A$0.80Volume655,096 shsAverage VolumeN/AMarket Capitalization$162.12 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trials for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia. Receive OPT News and Ratings via Email Sign-up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ASX Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolASX:OPT Previous Symbol CUSIPN/A CIKN/A Webhttp://www.opthea.com/ Phone61 3 9826 0399Debt Debt-to-Equity RatioN/A Current Ratio5.24 Quick Ratio5.22Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$187,574.00 Price / Sales864.30 Cash FlowA$0.15 per share Price / Cash Flow4.22 Book ValueA$0.16 per share Price / Book4.09Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares249,415,008Market Cap$162.12 million Next Earnings DateN/A OptionableNot Optionable Opthea (ASX:OPT) Frequently Asked Questions What is Opthea's stock symbol? Opthea trades on the ASX under the ticker symbol "OPT." Has Opthea been receiving favorable news coverage? News headlines about OPT stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Opthea earned a daily sentiment score of -1.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. Who are some of Opthea's key competitors? Some companies that are related to Opthea include Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Vita Life Sciences (VLS), Futura Medical (FUM), Cathay International (CTI), Patrys (PAB), Recce Pharmaceuticals (RCE), Avivagen (VIV), Antisense Therapeutics (ANP) and NanoViricides (NNVC). Who are Opthea's key executives? Opthea's management team includes the folowing people: Dr. Megan Baldwin Ph.D., MAICD, MD, CEO & Exec. DirectorMr. Michael Tonroe, CFO & Company Sec.Mr. Richard Chadwick Ph.D., Head of Intellectual PropertyDr. Michael Gerometta, Head of CMC Devel.Dr. Ian Leitch, Director of Clinical Research What is Opthea's stock price today? One share of OPT stock can currently be purchased for approximately A$0.65. How big of a company is Opthea? Opthea has a market capitalization of $162.12 million and generates $187,574.00 in revenue each year. What is Opthea's official website? The official website for Opthea is http://www.opthea.com/. How can I contact Opthea? The company can be reached via phone at 61 3 9826 0399. MarketBeat Community Rating for Opthea (ASX OPT)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 1 (Vote Outperform)Underperform Votes: 1 (Vote Underperform)Total Votes: 2MarketBeat's community ratings are surveys of what our community members think about Opthea and other stocks. Vote "Outperform" if you believe OPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Outstanding Shares, Buying and Selling Stocks Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.